tirzepatide for kidney disease (Zepbound) showed improved function in obese patients with both chronic kidney and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https SURPASS-CVOT: Tirzepatide Significantly Reduces Major

Wegovy is FDA approved for chronic weight management in adults with obesity and overweight with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol

The 1-acre riverside campus also includes the 1775 Folsom Tavern

Building on these data, here we assess whether the metabolic effects of such an incretin-conjugated PPAR agonist could further be enhanced by covalent tethering of Tesa to the peptide backbone of the DPP4-protected GLP-1RGIPR co-agonist MAR709 32 (Extended Data Fig

Conner Mertens 17:48 Youre welcome back anytime, folks

The decision to use diabetes medications in any combination outside standard guidance would usually be made by a diabetes specialist, taking into account your specific clinical circumstances and with a clear rationale and review plan

If detox support is part of your routine, explore our Detox collection